Acción MGRO MUSTGROW BIOLOGICS CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas MustGrow Biologics Corp.

Acciones

MGRO

CA62822A1030

Diferido Toronto S.E.
Otros sitios de cotización
 17:06:01 10/05/2024 		Varia. Cinco días. Varia. 1 de enero.
1,02 CAD -1,92 % Gráfico intradía de MustGrow Biologics Corp. 0,00 % -20,93 %
23/04 MustGrow Biologics Corp. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 CI
2023 Mustgrow Biologics Corp. anuncia la firma de un acuerdo de colaboración con Bayer AG CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
MustGrow Biologics Gains California Approval for Organic Biofertility Product, TerraSante
Mustgrow Biologics Corp. Receives California Department of Food Agriculture Registration Approval
MustGrow Receives California Registration and Organic Approval for TerraSante(TM) Biofertility Product
MustGrow Biologics Secures Distribution Agreement for TerraSante in Oregon and Washington State
MustGrow Signs Exclusive Distribution Agreement with G.S. Long Co., Inc. for TerraSante(TM) Biofertility Product
MustGrow Biologics : Year End 2023
MustGrow Biologics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
MustGrow Biologics to Present at the Planet MicroCap Showcase
MustGrow Receives Registration Approval for TerraSante(TM) in Oregon State
MustGrow Biologics Corp.(TSXV:MGRO) dropped from S&P/TSX Venture Composite Index
MustGrow Provides Additional Information and Clarification on Commercial License Agreement with Bayer
MustGrow Biologics agrees to commercial licence agreement with Bayer covering Europe, Middle East and Africa
Mustgrow Biologics Corp. Announces the Signing of Collaboration Agreement with Bayer AG
MustGrow Biologics and Bayer Sign Commercial License Agreement for Biocontrol Technologies in Europe, Middle East and Africa
MustGrow Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
MustGrow Biologics announces company has received approval for TerraSante in Washington State
MustGrow Biologics Corp. Receives Registration Approval for TerraSante in Washington State
MustGrow Receives Registration Approval for TerraSante(TM) in Washington State
MustGrow to Present at the Harbor Access Global SMID Cap Investor Conference November 16th
MustGrow Biologics Corp. Receives PMRA Approval to Commence Large Scale Field Trials via NexusBioAg BAT Program
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción MGRO
  4. Noticias MustGrow Biologics Corp.
  5. Otros idiomas